Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
biOasis Technologies Ord Shs
BIOAF
Primary Symbol:
V.BTI.H
Healthcare
Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in...
particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:BTI.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(144)
•••
unclepieman
X
View Profile
View Bullboard History
Comment by
unclepieman
on Mar 05, 2023 11:05pm
RE:RE:RE:$5.25 million
I suspect and anticipate a Zero! This company lasted about 10y longer than it should have, being a micro pharma scam. It is what it is, I rolled the dice and sometimes ... you get snake eyes and you
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Post by
Boomskid
on Mar 01, 2023 2:39pm
Protalix (PLX)
poof continues to keep the forum posted on the Protalix share price. Bioasis has no known relationship with Protalix. They may have, but it's being kept secret if it's true.
...more
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Post by
Boomskid
on Mar 01, 2023 2:28pm
Gaucher Disease
There was a reference to gene therapy and Gaucher Type 3 (GB3) pasted here by poof. I don't know what poof is trying to do because the news is hardly helpful to Bioasis. I've been posting for
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Mar 01, 2023 2:03pm
PLX breaks $2
$2.010.07 | 3.61% That's about a C$155 million market cap. The higher it goes the less potential dilution acquiring BTI. At its current price acquiring BTI for C$40 million would only
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Mar 01, 2023 1:51pm
RE:RE:RE:RE:Sangamo
First of all, I no longer have the faith and admiration you have for Saltarelli, poof. He approved the Midatech sellout and he was going to go with Biodexa. He gets a lot and Bioasis get next to
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Mar 01, 2023 1:05pm
RE:RE:RE:Sangamo
"Yes, Chiesi most certainly is patient and does have a long term view..." That's exciting. A top 50 pharma company with a long-term view and strategic focus on Lysosomal Storage and
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Mar 01, 2023 12:42pm
RE:RE:Sangamo
Yes, Chiesi most certainly is patient and does have a long term view, Why, it will be 3 years soon since Chiesi got 4 LSDs from Bioasis for almost nothing. And here we are, no news of what the
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Mar 01, 2023 12:32pm
RE:Sangamo
Chiesi is a top 50 global pharma company that has targeted Lysosomal Storage as a strategic focus. It is a very patient company directed at the long term. Mol Ther Methods Clin
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Post by
Boomskid
on Mar 01, 2023 12:17pm
xB3-004
It should be noted that Bioasis's interest in Fabry with xB3-004 does not relate to treating Fabry disease. xB3-004 may treat a symptom of Fabry, neuropathic pain, but not the disease itself
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Post by
Boomskid
on Mar 01, 2023 12:05pm
Sangamo
Bioasis has no immediate interest in Sangamo or any other reported efforts to treat Fabry disease. If Chiesi (and Protalix) move forward with an xB3 version of PRX-102 for Fabry, the most that
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Mar 01, 2023 11:54am
RE:British Columbia Securities Commission!!
I'm serious about doing this. Please let me know. jd
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Mar 01, 2023 11:54am
RE:Prohetoffactz's tactics
poof is now going to double down and flood the forum with meaningless posts. We need to deal with Fabry. Sangamo is alsmost meaningless to Bioasis. I'll have more to say, soon. jd
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Mar 01, 2023 11:38am
Gaucher's gene therapy trial
“Following gene therapy, we have seen real changes in our life and our son's life,” the patient’s parent shared..." HSC Gene Therapy Demonstrates Improvements in Type 3 Gaucher Disease Case
...more
(107)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Mar 01, 2023 11:09am
SGMO and Fabry
The stock is down over the last month with the market but... Sangamo Therapeutics Announces Evidence of Clinical Benefit in Phase 1/2 STAAR Study in Fabry Disease
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Mar 01, 2023 10:57am
RE:RE:Prohetoffactz's tactics
zwerp2000, it's obviously rather silly to say that nobody cares about Bioasis. I understand your desire to be provocative, but you have to start with a truth. It's
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
This $10M Deal Could Reshape the Future of Global Creator Platforms
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?